• Home
  •  / Cardiovascular Systems

Cardiovascular Systems

OverviewSuggest Edit

Cardiovascular Systems is a medical technology company that develops, manufactures, and markets devices to treat vascular diseases. The Company offers peripheral arterial disease products, which are catheter-based platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives. It also provides an atherectomy device for the treatment of calcified coronary arteries.

TypePublic
Founded1989
HQSaint Paul, MN, USMap
Websitecsi360.com
Employee Ratings4.1More
Overall CultureC-More
View Jobs (18)

Locations

Cardiovascular Systems is headquartered in
Saint Paul, United States

Location Map
All Locations (4)

Latest Updates

Employees (est.) (Jun 2019)731(+13%)
Job Openings18
Revenue (FY, 2020)$236.5 M(-4%)
Share Price (Nov 2021)$27.2
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Cardiovascular Systems

Scott R. Ward

Scott R. Ward

President and CEO
Ryan D. Egeland

Ryan D. Egeland

Chief Medical Officer
Jeff Points

Jeff Points

CFO
John M. Hastings

John M. Hastings

Vice President, Manufacturing & Operations
Rhonda Robb

Rhonda Robb

COO
Jeffrey S. Points

Jeffrey S. Points

Chief Financial Officer
Show more

Cardiovascular Systems Office Locations

Cardiovascular Systems has offices in Saint Paul and Rochester
Saint Paul, MN, US (HQ)
1225 Old Hwy 8 NW
Rochester, NY, US
Campus Drive
Saint Paul, MN, US
Como Park Zoo & Conservatory, 1225 Estabrook Dr
Show all (4)

Cardiovascular Systems Financials and Metrics

Cardiovascular Systems Revenue

Embed Graph
View revenue for all periods
Cardiovascular Systems's revenue was reported to be $236.55 m in FY, 2020
USD

Revenue (Q2, 2021)

64.2m

Gross profit (Q2, 2021)

50.2m

Gross profit margin (Q2, 2021), %

78.3%

Net income (Q2, 2021)

(56.0k)

EBIT (Q2, 2021)

283.0k

Market capitalization (12-Nov-2021)

1.1b

Closing stock price (12-Nov-2021)

27.2

Cash (31-Dec-2020)

73.8m
Cardiovascular Systems's current market capitalization is $1.1 b.
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

82.5m103.9m136.6m181.5m178.2m204.9m217.0m248.0m236.5m

Revenue growth, %

33%(2%)

Cost of goods sold

19.2m24.4m31.0m39.5m35.4m39.4m39.5m47.7m48.8m

Gross profit

63.3m79.5m105.6m142.0m142.8m165.5m177.6m200.3m187.8m
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q2, 2021

Revenue

18.7m19.7m21.2m23.3m25.3m26.5m29.8m32.3m34.9m41.4m44.7m47.0m43.9m41.4m44.5m49.8m50.0m52.1m49.7m52.6m55.6m56.3m60.2m63.3m64.5m68.3m61.2m64.2m

Cost of goods sold

4.3m4.6m5.1m5.3m6.0m6.2m6.9m7.3m7.7m8.9m9.3m10.4m8.8m8.1m8.7m9.5m9.2m11.1m9.2m9.5m10.0m10.6m11.5m12.2m12.7m13.7m12.2m13.9m

Gross profit

14.3m15.2m16.1m18.0m19.4m20.2m22.9m25.0m27.2m32.5m35.4m36.6m35.1m33.3m35.7m40.3m40.9m41.0m40.5m43.1m45.6m45.7m48.7m51.1m51.8m54.6m49.0m50.2m

Gross profit Margin, %

77%77%76%77%76%76%77%77%78%79%79%78%80%81%80%81%82%79%81%82%82%81%81%81%80%80%80%78%
show all
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

35.5m67.9m126.6m83.8m60.6m107.9m116.3m74.2m185.5m

Accounts Receivable

13.6m14.7m21.4m30.8m23.1m28.5m31.2m36.0m25.2m

Prepaid Expenses

1.5m959.0k1.8m3.4m5.1m3.0m3.3m2.6m

Inventories

7.1m6.2m12.9m14.0m17.4m16.9m16.6m18.1m27.7m
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q2, 2021

Cash

22.7m24.6m22.5m32.2m29.2m69.9m63.2m146.7m146.0m116.4m101.3m93.5m76.7m65.3m62.2m58.2m79.3m103.1m104.7m107.3m109.3m113.4m118.8m115.3m58.9m65.5m69.6m73.8m

Accounts Receivable

11.8m12.5m13.0m13.5m13.0m15.2m15.3m15.9m19.5m22.4m26.1m31.2m26.9m25.8m23.0m24.3m25.4m27.9m27.3m27.9m31.9m30.3m29.9m35.0m34.6m35.8m30.9m32.5m

Prepaid Expenses

1.2m1.4m980.0k1.2m1.1m778.0k1.5m1.0m3.6m4.1m3.9m2.6m1.6m1.4m2.0m1.4m3.5m6.0m2.6m2.4m2.2m1.9m2.2m2.9m3.0m2.2m3.0m

Inventories

7.1m8.0m7.8m7.0m7.2m6.8m8.3m10.3m11.9m14.6m14.0m13.2m15.4m18.2m18.2m16.9m16.2m16.6m17.0m17.4m17.0m18.1m19.7m19.3m19.5m21.5m24.1m32.5m
show all
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(16.8m)(24.0m)(35.3m)(32.8m)(56.0m)(1.8m)1.7m(255.0k)(27.2m)

Depreciation and Amortization

55.0k70.0k124.0k171.0k3.9m4.1m3.9m3.4m4.2m

Inventories

(1.2m)818.0k(6.6m)(1.1m)(3.5m)543.0k292.0k(1.5m)(9.6m)

Accounts Payable

269.0k1.5m4.6m581.0k(970.0k)1.8m104.0k566.0k576.0k
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q2, 2021

Net Income

(3.9m)(8.0m)(12.2m)(5.2m)(11.0m)(17.2m)(7.3m)(15.9m)(25.7m)(8.2m)(13.5m)(24.2m)(13.3m)(28.4m)(51.1m)(1.9m)(815.0k)(2.6m)(2.0m)(2.4m)(2.0m)(2.9m)(2.4m)(1.7m)(5.8m)(9.2m)(12.1m)(2.1m)

Depreciation and Amortization

40.0k144.0k293.0k102.0k138.0k408.0k833.0k1.4m973.0k2.0m2.9m1.8m2.8m3.8m1.0m2.1m3.6m854.0k1.7m2.6m974.0k2.1m3.2m2.1m

Inventories

(1.2m)(2.1m)(2.0m)99.0k(100.0k)265.0k(2.0m)(4.0m)(5.6m)(1.8m)(1.1m)(329.0k)(1.5m)(4.3m)(4.3m)553.0k1.3m835.0k(138.0k)(504.0k)(105.0k)(1.5m)(3.1m)(2.7m)(1.4m)(3.4m)(6.0m)(4.8m)

Accounts Payable

22.0k452.0k(109.0k)(156.0k)(799.0k)451.0k1.3m1.4m4.0m2.1m467.0k2.7m(18.0k)(1.1m)(1.4m)257.0k(1.0m)190.0k229.0k(608.0k)(544.0k)2.5m1.5m1.9m2.1m5.4m2.0m2.2m
show all
USDQ1, 2012

Financial Leverage

2.1 x
Show all financial metrics

Cardiovascular Systems Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

Learn more about our premium products
SecurityScorecard logo

Cardiovascular Systems Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

Learn more about our premium products
CSRHub logo

Cardiovascular Systems Online and Social Media Presence

Cardiovascular Systems's Trends

Embed Graph

Cardiovascular Systems Company Culture

  • Overall Culture

    C-

    66/100

  • CEO Rating

    F

    55/100

  • Compensation

    C-

    63/100

Learn more on Comparably

 Cardiovascular Systems Frequently Asked Questions

  • When was Cardiovascular Systems founded?

    Cardiovascular Systems was founded in 1989.

  • Who are Cardiovascular Systems key executives?

    Cardiovascular Systems's key executives are Scott R. Ward, Ryan D. Egeland and Jeff Points.

  • How many employees does Cardiovascular Systems have?

    Cardiovascular Systems has 731 employees.

  • What is Cardiovascular Systems revenue?

    Latest Cardiovascular Systems annual revenue is $236.5 m.

  • What is Cardiovascular Systems revenue per employee?

    Latest Cardiovascular Systems revenue per employee is $323.6 k.

  • Who are Cardiovascular Systems competitors?

    Competitors of Cardiovascular Systems include Spectranetics, LeMaitre Vascular and Ra Medical Systems.

  • Where is Cardiovascular Systems headquarters?

    Cardiovascular Systems headquarters is located at 1225 Old Hwy 8 NW, Saint Paul.

  • Where are Cardiovascular Systems offices?

    Cardiovascular Systems has offices in Saint Paul and Rochester.

  • How many offices does Cardiovascular Systems have?

    Cardiovascular Systems has 4 offices.